First, in patients with chronic lymphocytic leukemia (CLL), AML, or adult acute lymphoblastic leukemia (ALL), TIGIT is commonly upregulated on CD4+ T cells, CD8+ T cells, Foxp3 + γδ T cells, or NK cells compared with healthy individuals [64–70]. This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.